Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Rophibio Inc.
Sponsor

Rophibio Inc.

Room 406 194-25 Osongsaengmyeong 1-Ro, 28160

About the sponsor

Rophibio Inc. is involved in clinical research focused on neovascular age-related macular degeneration, a leading cause of vision loss associated with abnormal blood vessel growth in the retina.

  • Age-related macular degeneration
  • Retinal vascular disorders
  • Macular pathology

The sponsor’s activity is centered on treatments intended to address visual impairment linked to macular degeneration and related retinal damage.

About Specializations

Rophibio Inc. runs clinical trials in conditions such as Neovascular age-related macular degeneration, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Neovascular age-related macular degeneration

Not recruiting
Registered drugNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Rophibio Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.